NL-OMON55730招募中不适用
proSpecTive sAmpling in dRiver muTation pulmonary oncology patients on Tyrosine Kinase Inhibitors - START-TKI
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >= 18 years
- •Able to understand the written informed and able to give informed consent
- •Locally advanced or metastatic lung cancer with oncogenic driver mutation
- •Treatment with TKI according to standard of care
排除标准
- •Unable to draw blood for study purposes
研究者
相似试验
招募中
不适用
ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)Non Small Cell Lung CancerLiquid BiopsyTyrosine Kinase InhibitorNCT05221372Erasmus Medical Center1,300
尚未招募
不适用
Diagnostic performance of respiratory specimens in critically ill intubated COVID19 patients.CTRI/2021/03/032451Christian Medical College
已完成
不适用
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung CancerLung Cancer (Diagnosis)NCT03633006Exact Sciences Corporation3,298
尚未招募
3 期
A study to find out the effectiveness of Homoeopathic medicines in Allergic asthma patientsCTRI/2022/10/046524Dr GEETHU K P
已完成
不适用
Acquisition and transmission of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosisHuman Genetics and Inherited Disorders - Cystic fibrosisCystic FibrosisACTRN12605000628640A/Prof Claire Wainwright20